Sökning: WFRF:(Aul C) > (2010-2014) > Patients with del(5...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 01362naa a2200325 4500 | |
001 | oai:prod.swepub.kib.ki.se:120046051 | |
003 | SwePub | |
008 | 240701s2010 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1200460512 URI |
024 | 7 | a https://doi.org/10.1007/s00277-009-0846-z2 DOI |
040 | a (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Gohring, G4 aut |
245 | 1 0 | a Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression |
264 | c 2009-10-24 | |
264 | 1 | b Springer Science and Business Media LLC,c 2010 |
700 | 1 | a Giagounidis, A4 aut |
700 | 1 | a Busche, G4 aut |
700 | 1 | a Kreipe, HH4 aut |
700 | 1 | a Zimmermann, M4 aut |
700 | 1 | a Hellstrom-Lindberg, Eu Karolinska Institutet4 aut |
700 | 1 | a Aul, C4 aut |
700 | 1 | a Schlegelberger, B4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Annals of hematologyd : Springer Science and Business Media LLCg 89:4, s. 365-374q 89:4<365-374x 1432-0584x 0939-5555 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:120046051 |
856 | 4 8 | u https://doi.org/10.1007/s00277-009-0846-z |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.